A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and suicidality in a military emergency department setting

Military Medicine

Volumn 181, Issue 10, 2016, Pages 1195-1199

  Burger, John ^a   Capobianco, Marc ^a   Lovern, Robert ^a   Boche, Ben ^a   Ross, Elliot ^a   Darracq, Michael A ^a   McLay, Robert ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; KETAMINE; PLACEBO;

ADULT; CONTROLLED STUDY; DEPRESSION; DISSOCIATIVE DISORDER; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITAL EMERGENCY SERVICE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORGANIZATION AND MANAGEMENT; PILOT STUDY; PSYCHOLOGY; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; SOLDIER; SUICIDE; SUICIDE ATTEMPT;

ADMINISTRATION, INTRAVENOUS; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISSOCIATIVE DISORDERS; DOUBLE-BLIND METHOD; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS, MILITARY; HUMANS; KETAMINE; MALE; MILITARY PERSONNEL; PILOT PROJECTS; PLACEBOS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 84990985973     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-15-00431     Document Type: Article

References (29)

1. Department of Defense Suicide Event Report: Calendar Year 2012 Annual Report. Available at http://t2health.dcoe.mil/sites/default/files/ dodser_ar2012_20140306_0.pdf; accessed December 15, 2015.
2. Trivedi M, Rush A, Wisniewski S, et al: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D:implications for clinical practice. Am J Psychiatry 2006; 163:28-40.
3. Miller RM, Eriksson LI, Fleisher LA, Weiner-Kronish JP, Young WL:Millers Anesthesia, 7th Edition, 2009.
4. National Drug Intelligence Center: Intelligence Bulletin: Ketamine. Available at www.justice.gov/archive/ndic/pubs10/10255.
5. Berman RM, Cappiello A, Anand A, et al: Antidepresant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47:351-4.
6. Zarate CA Jr, Singh JB, Carlson PJ, et al: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856-64.
7. Valentine GW, Mason GF, Gomez R, et al: The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by 1H-MRS. Psychiatry Res 2011; 191:122-7.
8. Bunney BG, Bunney WE: Rapid-acting antidepressant strategies: mechanisms of action. Int J Neuropsychopharmacol 2012; 15:695-713.
9. aan het Rot M, Collins KA, Murrough JW, et al: Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 2010; 67:139-45.
10. Ibrahim L, DiazGranados N, Luckenbaugh DA, et al: Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECTresistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:1155-9.
11. Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A: Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci 2011; 261:575-82.
12. Kudoh A, Takahira Y, Katagai H, Takazawa T: Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 2002; 95:114-8.
13. DiazGranados N, Ibrahim L, Brutsche NE, et al: A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67:793-802.
14. Zarate CA Jr, Brutsche NE, Ibrahim L, et al: Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012; 71:939-46.
15. Price RB, Nock MK, Charney DS, Mathew SJ: Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatmentresistant depression. Biol Psychiatry 2009; 66:522-6.
16. Phelps LE, Brutsche N, Moral JR, Luckenbaugh DA, Manji HK, Zarate CA Jr: Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry 2009; 65:181-84.
17. DiazGranados N, Ibrahim LA, Brutsche NE, et al: Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 2010; 71:1605-11.
18. Price RB, Iosifescu DV, Murrough JW, et al: Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety 2014; 31:335-43.
19. Reinstatler LJ, Youssef NA: Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. Drugs R&D 2015; 15:37-43.
20. Panzer O, Moitra V, Slader RN: Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin 2009; 25:451-69.
21. Strayer RJ, Nelson LS: Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med 2008; 26:985-1028.
22. Krystal JH, Karper LP, Seibyl JP, et al: Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Genl Psychiatry 1994; 51:199-214.
23. Krystal JH, Karper LP, Bennett A, et al: Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology 1998; 135:213-29.
24. Sethna NF, Liu M, Gracely R, Bennett GJ, Max MB: Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects. Anesth Analg 1998; 86:1250-6.
25. Larkin GL, Beautrais AL: A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsycholpharmacol 2011; 14:1127-31.
26. Range LM, Knott EC: Twenty suicide assessment instruments: Evaluation and recommendations. Death Stud 1997; 21:25-58.
27. Beck AT, Steer RA, Kovacs M, Garrison B: Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985; 142:559-63.
28. Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA: Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 1990; 147:190-5.
29. Beck AT, Steer RA, Beck JS, Newman CF: Hopelessness, depression, suicidal ideation, and clinical diagnosis of depression. Suicide Life Threat Behav 1993; 23:139-45.